What did @james.madeson2 actually say?
The creator describes MK-677 as a "growth hormone secretagogue" that works through "ghrelin response," and insists it must be taken in a fasted state to work properly. He doses at 30mg nightly, about two hours after his last meal, and claims this timing produces fat burning, better sleep, and "homeostasis for energy release." He also flags water retention as a side effect and offers three mitigation strategies: reduce sodium, control food intake, and stick to fasted nighttime dosing.
He clarifies upfront that MK-677 is neither a steroid nor a SARM, which is worth noting because that misconception is common in bodybuilding communities. The ghrelin angle is where things get interesting, and also where the explanation starts to slip.
Does the science back this up?
Partially. MK-677 is a ghrelin mimetic, not exactly a ghrelin releaser, and that distinction matters. The mechanism is reasonably well-documented. Murphy et al. (1998, Journal of Clinical Endocrinology and Metabolism) confirmed MK-677 stimulates GH and IGF-1 secretion by mimicking ghrelin's action at the GHSR-1a receptor. The fat-burning claim in a fasted state has a biological rationale: GH pulses are amplified when insulin is low, and Nass et al. (2008, Journal of Clinical Endocrinology and Metabolism) showed sustained IGF-1 elevation with oral MK-677 in older adults. Nighttime dosing aligns with natural GH pulsatility, which peaks during slow-wave sleep. So the timing logic is not invented.
That said, the evidence base here is almost entirely from short clinical trials in elderly or GH-deficient populations. Extrapolating those findings to healthy bodybuilders doing 30mg doses is a significant leap that no peer-reviewed study has validated.
What did they get wrong (or right)?
The biggest error is the mechanism description. MK-677 does not "increase your body's natural production or release of ghrelin." It mimics ghrelin by binding to the same receptor. Circulating ghrelin levels do not necessarily rise. This is a meaningful difference because it affects how you think about side effects and interactions, not just a semantic quibble.
The sodium and water retention advice is directionally correct. MK-677 can elevate aldosterone-related fluid retention, and sodium moderation is a reasonable practical response. Sigalos and Pastuszak (2018, Sexual Medicine Reviews) noted edema as one of the more common reported side effects in users.
Calling it a fat burner is oversimplified. GH has lipolytic properties, but MK-677 also significantly increases appetite, which can easily offset any fat mobilization. The "burn fat in a fasted state" framing presents one mechanism while ignoring the opposing one.
Credit where it is due: he correctly identifies it as neither a steroid nor a SARM, and the sleep quality observation is consistent with GH's role in slow-wave sleep architecture, which is documented.
What should you actually know?
MK-677 remains an investigational compound. It has never received FDA approval for any indication. That means every bottle circulating in supplement or research chemical markets is unregulated, and purity and dosing accuracy are not guaranteed. The 30mg dose the creator describes is at the high end of what clinical studies have used, and higher doses do not linearly increase benefit while side effects including insulin resistance, increased fasting glucose, and edema become more pronounced. Smith et al. (1997, Science) established the foundational pharmacology, but clinical use in healthy adults at bodybuilding doses has not been systematically studied for safety.
Water retention is not just a cosmetic nuisance. Chronic edema and elevated glucose are worth monitoring if someone is using this compound long-term. Anyone considering MK-677 should have baseline bloodwork, including fasting glucose, HbA1c, and IGF-1, reviewed by a licensed provider before and during use.